Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

C. Bellera , N. Penel , M. Ouali , S. Bonvalot , P. Casali , S. Nielsen , M. Delannes , S. Litière , F. Bonnetain , S. Dabakuyo (1) , S. Benjamin , J.-Y. Blay , B. Bui , F. Collin , T. Delaney , F. Duffaud , T. Filleron , M. Fiore , H. Gelderblom , S. George , R. Grimer , P. Grosclaude (2) , A. Gronchi , R. Haas , P. Hohenberger , R. Issels , A. Italiano , V. Jooste , A. Krarup-Hansen , C. Le Péchoux , C. Mussi , O. Oberlin , S. Patel , S. Piperno-Neumann , C. Raut , Isabelle Ray-Coquard , P. Rutkowski , S. Schuetze , S. Sleijfer , E. Stoeckle , M. van Glabbeke , P. Woll , S. Gourgou-Bourgade , S. Mathoulin-Pelissier

1 CEP - Centre d'épidémiologie des populations
2 Registre général des cancers du Tarn = Tarn Cancer Registry

Domaines: Sciences du Vivant [q-bio]

C. Bellera, N. Penel, M. Ouali, S. Bonvalot, P. Casali, et al.. Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). Annals of Oncology, 2015, ⟨10.1093/annonc/mdu360⟩. ⟨hal-01912106⟩